Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Periprostatic Adipose Tissue Promotes Prostate Cancer Progression through Androgen Receptor-Mediated Lipolysis.

Created on 16 Nov 2026

Authors

Shiting Zhao, Yuang Wei, Jiexiang Zhang, Yang Chen, Lei Li, Qiaoyun Long, Ping Gu, Wei Sun, Zhaoxi Zhang, Sharon Keying Ma, Shiqing Liang, Ziyu Zhao, Qing Liu, Mengyuan Xie, Jiayu Zhao, Yifan Zhao, Yi He, Tao Nie, Bin Lu, Jiaqing Shao, Fuwen Yuan, Song Xue, Andrew Man Lok Chan, Jie Li, Gang Xiao, Donghai Wu, Dongliang Xu, Hannah Xiaoyan Hui

Published in

Advanced science (Weinheim, Baden-Wurttemberg, Germany). Nov 16, 2026. Epub Nov 16, 2026.

Abstract

Periprostatic adipose tissue (PPAT), a specialized fat depot surrounding the prostate gland, is linked to poor prostate cancer (PCa) prognosis. However, the mechanisms underlying the crosstalk between PPAT and PCa progression remain poorly understood. We found that PCa tumors, particularly aggressive ones, actively stimulated androgen receptor (AR) expression in PPAT, with elevated AR expression and signaling in PPAT being associated with aggressive PCa. Adipocyte-specific AR overexpression was sufficient to promote PCa growth in vitro and in vivo. Mechanistically, AR directly suppressed the E3 ligase RNF213, and RNF213 depletion increased hormone-sensitive lipase (HSL) protein abundance. Consequently, AR-driven lipolysis liberated free fatty acids (FFA) and promoted PCa cell growth and tumor microenvironment remodeling. Clinically, PPAT in high-risk PCa patients exhibited elevated lipolytic activity and reduced RNF213 expression. The PPAT conditioned medium (CM) of high-risk PCa patients enhanced PCa cell proliferation, which was reversed by blocking fatty acid uptake. Targeting this axis with the antilipolytic drug Acipimox significantly attenuated PCa growth in vivo. Our findings support a feed-forward interaction between prostate tumors and adipocyte AR signaling that promotes disease progression. This self-reinforcing cycle accelerates disease progression, and targeting PPAT lipolysis may represent a promising therapeutic strategy.

PMID:
43036288
Bibliographic data and abstract were imported from PubMed on 16 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 8
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement